NCT06943534View on ClinicalTrials.gov

Omalizumab Weight-Based Dosing Efficacy Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

April 1, 2028

Conditions
AllergiesFood Allergy
Interventions
DRUG

5mg/kg omalizumab injection

5mg/kg of omalizumab

DRUG

15mg/kg omalizumab injection

15mg/kg of omalizumab

Trial Locations (3)

27599

NOT_YET_RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

75390

NOT_YET_RECRUITING

University of Texas Southwestern, Dallas

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT06943534 - Omalizumab Weight-Based Dosing Efficacy Trial | Biotech Hunter | Biotech Hunter